Newborn screening showing decreasing incidence of cystic fibrosis

New England Journal of Medicine

Volumn 358, Issue 9, 2008, Pages 973-974

  Hale, Jaime E ^a   Parad, Richard B ^a   Comeau, Anne Marie ^a  

^a New England Newborn Screening Program   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHI SQUARE TEST; CYSTIC FIBROSIS; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; FOLLOW UP; GENOTYPE; HEALTH CARE ORGANIZATION; HUMAN; INCIDENCE; LETTER; MEDICAL GENETICS; NEWBORN CARE; NEWBORN SCREENING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REGISTER; UNITED STATES; GENETICS; NEWBORN;

CYSTIC FIBROSIS; GENOTYPE; HUMANS; INFANT, NEWBORN; MASSACHUSETTS; NEONATAL SCREENING;

EID: 40049109565     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0707530     Document Type: Letter

References (4)

1. Atkinson K, Zuckerman B, Sharfstein JM, Levin D, Blatt RJR, Koh HK. A public health response to emerging technology: expansion of the Massachusetts newborn screening program. Public Health Rep 2001;116:122-31.
2. Comeau AM, Parad RB, Dorkin HL, et al. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics 2004;113:1573-81.
3. Grody WW, Cutting GR, Klinger KW, et al. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001;3:149-54.
4. Cystic Fibrosis Foundation. Treatments. (Accessed January 31, 2008, at http://www.cff.org/treatments/.)